Skip to main content
SpringerLink
Log in

Improving the Recognition of, and Response to In-Hospital Sepsis

  • Sepsis and ICU (JL Vincent, Section Editor)
  • Published:
Current Infectious Disease Reports Aims and scope Submit manuscript

Abstract

Sepsis is an important cause of patient morbidity and mortality worldwide. Although the associated mortality seems to be decreasing, approximately 20 % of patients with organ dysfunction die in hospital. Since 1991 diagnostic criteria for sepsis focused on the systemic inflammatory response syndrome (SIRS). However, the utility of such criteria has been questioned, and alternative criteria have recently been proposed. It is likely that administration of early appropriate antibiotics and resolution of shock reduce sepsis-associated mortality. Accordingly, strategies need to be developed to improve the early recognition of, and response to patients with sepsis. Such system approaches may include improved acquisition and documentation of vital signs, enhanced recognition of shock, and integration of laboratory and microbiological results using clinical informatics. Hospitals should have guidelines for escalating care of septic patients, antibiotics stewardship programs, and systems to audit morbidity and mortality associated with sepsis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Stearns-Kurosawa D, Osuchowski MF, Valentine C, et al. The pathogensis of sepsis. Annu Rev Pathol. 2011;6:19–48.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/ Society of Critical Care Medicine. Chest. 1992;101(6):1644–55.

    Article  CAS  PubMed  Google Scholar 

  3. Dellinger RP, Levy MM, Carlet JM, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med. 2008;34(1):17–60.

    Article  PubMed  Google Scholar 

  4. Bochicchio GV, Napolitano LM, Joshi M, et al. Systemic inflammatory response syndrome score at admission independently predicts infection in blunt trauma patients. J Trauma. 2001;50:817–20.

    Article  CAS  PubMed  Google Scholar 

  5. Malone DL, Kuhls D, Napolitano LM, et al. Back to basics: validation of the admission systemic inflammatory response syndrome score in predicting outcome in trauma. J Trauma. 2001;51:458–63.

    Article  CAS  PubMed  Google Scholar 

  6. Napolitano LM, Ferrer T, McCarter R, et al. Systemic inflammatory response syndrome score at admission independently predicts mortality and length of stay in trauma patients. J Trauma. 2000;49:647–52.

    Article  CAS  PubMed  Google Scholar 

  7. Yoshimoto Y, Tanaka T, Hoya K. Acute systemic inflammatory response syndrome in subarachnoid hemorrhage. Stroke. 2001;32:1989–93.

    Article  CAS  PubMed  Google Scholar 

  8. Afessa B. Systemic inflammatory response syndrome in patients hospitalized for gastrointestinal bleeding. Crit Care Med. 1999;27:554–7.

    Article  CAS  PubMed  Google Scholar 

  9. Sun D, Aikawa N. The natural history of the systemic inflammatory response syndrome and the evaluation of SIRS criteria as a predictor of severity in patients hospitalized through emergency services. Keio J Med. 1999;48:28–37.

    Article  CAS  PubMed  Google Scholar 

  10. Asayama K, Aikawa N. Evaluation of systemic inflammatory response syndrome criteria as a predictor of mortality in emergency patients transported by ambulance. Keio J Med. 1998;47:19–27.

    Article  CAS  PubMed  Google Scholar 

  11. Sprung CL, Sakr Y, Vincent JL, et al. An evaluation of systemic inflammatory response syndrome signs in the Sepsis Occurrence in Acutely Ill Patients (SOAP) study. Intensive Care Med. 2006;32(3):421–7.

    Article  PubMed  Google Scholar 

  12. Pittet D, Rangel-Frausto S, Li N, et al. Systemic inflammatory response syndrome, sepsis, severe sepsis and septic shock: incidence, morbidities and outcomes in surgical ICU patients. Intensive Care Med. 1995;21(4):302–9.

    Article  CAS  PubMed  Google Scholar 

  13. Vincent JL. Dear SIRS, I’m sorry to say that I don’t like you. . . . Crit Care Med. 1997;25(2):372–4.

    Article  CAS  PubMed  Google Scholar 

  14. Kaukonen KM, Bailey M, Pilcher D, et al. Systemic inflammatory response syndrome criteria in defining severe sepsis. N Engl J Med. 2015;372(17):1629–38.

    Article  CAS  PubMed  Google Scholar 

  15. Vincent JL, Opal SM, Marshall JC, Tracey KJ. Sepsis definitions: time for change. Lancet. 2013;381(9868):774–5.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Churpek MM, Zadravecz FJ, Winslow C, et al. Incidence and prognostic value of the systemic inflammatory response syndrome and organ dysfunctions in ward patients. Am J Respir Crit Care Med. 2015;192(8):958–64.

    Article  PubMed  Google Scholar 

  17. Klein Klouwenberg PM, Ong DS, Bonten MJ, Cremer OL. Classification of sepsis, severe sepsis and septic shock: the impact of minor variations in data capture and definition of SIRS criteria. Intensive Care Med. 2012;38(5):811–9.

    Article  PubMed  Google Scholar 

  18. Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ACCP/ ATS/SIS international sepsis definitions conference. Crit Care Med. 2003;31(4):1250–6.

    Article  PubMed  Google Scholar 

  19. Dugas AF, Mackenhauer J, Salciccioli JD, et al. Prevalence and characteristics of nonlactate and lactate expressors in septic shock. J Crit Care. 2012;27(4):344–50.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Pedro Póvoa C-reactive protein: a valuable marker of sepsis. Intensive Care Med. 2002; 28: 235–243.

  21. Uzzan B, Cohen R, Nicolas P, et al. Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis. Crit Care Med. 2006;34:1996–2003.

    Article  CAS  PubMed  Google Scholar 

  22. Lee SH, Chan RC, Wu JY, et al. Diagnostic value of procalcitonin for bacterial infection in elderly patients—a systemic review and meta-analysis. Int J Clin Pract. 2013;67(12):1350–7.

    Article  PubMed  Google Scholar 

  23. Tang BM, Eslick GD, Craig JC, et al. Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis. Lancet Infect Dis. 2007;7(3):210–7.

    Article  CAS  PubMed  Google Scholar 

  24. Albrich WC, Harbarth S. Pros and cons of using biomarkers versus clinical decisions in start and stop decisions for antibiotics in the critical care setting. Intensive Care Med. 2015;41(10):1739–51.

    Article  PubMed  Google Scholar 

  25. Marshall JC, Reinhart K. International Sepsis Forum. Biomarkers of sepsis. Crit Care Med. 2009;37(7):2290–8.

    Article  CAS  PubMed  Google Scholar 

  26. Skibsted S, Bhasin MK, Aird WC, Shapiro NI. Bench-to-bedside review: future novel diagnostics for sepsis—a systems biology approach. Crit Care. 2013;17(5):231.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Finfer S, Bellomo R, Lipman J, et al. Adult population incidence of severe sepsis in Australian and New Zealand intensive care units. Intensive Care Med. 2004;30(4):589–96.

    Article  PubMed  Google Scholar 

  28. Martin CM, Priestap F, Fisher H, et al. STAR Registry Investigators. A prospective, observational registry of patients with severe sepsis: the Canadian Sepsis Treatment and Response Registry. Crit Care Med. 2009;37(1):81–8.

    Article  PubMed  Google Scholar 

  29. Salvo I, de Cian W, Musicco M, et al. The Italian SEPSIS study: preliminary results on the incidence and evolution of SIRS, sepsis, severe sepsis and septic shock. Intensive Care Med. 1995;21 Suppl 2:S244–9.

    Article  PubMed  Google Scholar 

  30. Quenot JP, Binquet C, Kara F, et al. The epidemiology of septic shock in French intensive care units: the prospective multicenter cohort EPISS study. Crit Care. 2013;17(2):R65.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Annane D, Aegerter P, Jars-Guincestre MC, Guidet B. CUB-Réa Network. Current epidemiology of septic shock: the CUB-Réa Network. Am J Respir Crit Care Med. 2003;168(2):165–72.

    Article  PubMed  Google Scholar 

  32. Whittaker SA, Fuchs BD, Gaieski DF, et al. Epidemiology and outcomes in patients with severe sepsis admitted to the hospital wards. J Crit Care. 2015;30(1):78–84.

    Article  PubMed  Google Scholar 

  33. Peake SL, Bailey M, Bellomo R, ARISE Investigators, for the Australian and New Zealand Intensive Care Society Clinical Trials Group, et al. Australasian resuscitation of sepsis evaluation (ARISE): a multi-centre, prospective, inception cohort study. Resuscitation. 2009;80(7):811–8.

    Article  PubMed  Google Scholar 

  34. ARISE; ANZICS APD Management Committee. The outcome of patients with sepsis and septic shock presenting to emergency departments in Australia and New Zealand. Crit Care Resusc. 2007;9(1):8–18.

    Google Scholar 

  35. Filbin MR, Arias SA, Camargo Jr CA, et al. Sepsis visits and antibiotic utilization in U.S. emergency departments. Crit Care Med. 2014;42(3):528–35.

    Article  PubMed  Google Scholar 

  36. Powell ES, Khare RK, Courtney DM, et al. Volume of emergency department admissions for sepsis is related to inpatient mortality: results of a nationwide cross-sectional analysis. N Engl J Med. 2003;348(16):1546–54.

    Article  Google Scholar 

  37. Martin GS, Mannino DM, Eaton S, et al. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 2003;348(16):1546–54.

    Article  PubMed  Google Scholar 

  38. Dombrovskiy VY, Martin AA, Sunderram J, Paz HL. Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003. Crit Care Med. 2007;35(5):1244–50.

    Article  PubMed  Google Scholar 

  39. Brun-Buisson C, Meshaka P, Pinton P, et al. EPISEPSIS: a reappraisal of the epidemiology and outcome of severe sepsis in French intensive care units. Intensive Care Med. 2004;30:580–8.

    Article  CAS  PubMed  Google Scholar 

  40. Rangel-Frausto S, Pittet D, Costigan M, et al. The natural history of the systemic inflammatory response syndrome (SIRS). JAMA. 1995;273(2):117–23.

    Article  CAS  PubMed  Google Scholar 

  41. Douglas L, Casamento A, Robbins R, et al. Point prevalence of patients fulfilling SIRS criteria in a teaching hospital. Intern Med J. 2016;46:223–5.

    Article  CAS  PubMed  Google Scholar 

  42. Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001;345(19):1368–77.

    Article  CAS  PubMed  Google Scholar 

  43. Peake SL, Delaney A, Bailey M, ARISE Investigators; ANZICS Clinical Trials Group, et al. Goal-directed resuscitation for patients with early septic shock. N Engl J Med. 2014;371(16):1496–506.

    Article  CAS  PubMed  Google Scholar 

  44. Mouncey PR, Osborn TM, Power GS, et al. ProMISe Trial Investigators. Trial of early, goal-directed resuscitation for septic shock. N Engl J Med. 2015;372(14):1301–11.

    Article  CAS  PubMed  Google Scholar 

  45. Yealy DM, Kellum JA, Huang DT, ProCESS Investigators, et al. A randomized trial of protocol-based care for early septic shock. N Engl J Med. 2014;370(18):1683–93.

    Article  CAS  PubMed  Google Scholar 

  46. Kaukonen KM, Bailey M, Suzuki S, et al. Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000–2012. JAMA. 2014;311(13):1308–16.

    Article  CAS  PubMed  Google Scholar 

  47. Kaukonen KM, Bailey M, Bellomo R. Systemic inflammatory response syndrome criteria for severe sepsis. N Engl J Med. 2015;373(9):881.

    PubMed  Google Scholar 

  48. Singer M, Deutschman, CS, Seymour CW, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016

  49. Gloria Vazquez-Grande MD, Anand Kumar MD. Optimizing antimicrobial therapy of sepsis and septic shock: focus on antibiotic combination therapy. Semin Respir Crit Care Med. 2015;36:154–66.

    Article  PubMed  Google Scholar 

  50. Johnson MT, Reichley R, Hoppe-Bauer J, et al. Impact of previous antibiotic therapy on outcome of Gram-negative severe sepsis. Crit Care Med. 2011;39(8):1859–65.

    Article  CAS  PubMed  Google Scholar 

  51. de Groot B, Ansems A, Gerling DH, et al. The association between time to antibiotics and relevant clinical outcomes in emergency department patients with various stages of sepsis: a prospective multi-center study. Crit Care. 2015;19:194.

    Article  PubMed  PubMed Central  Google Scholar 

  52. Lodise Jr TP, Lomaestro B, Drusano GL. Piperacillin-tazobactam for Pseudomonas aeruginosa infection: clinical implications of an extended- infusion dosing strategy. Clin Infect Dis. 2007;44(3):357–63.

    Article  CAS  PubMed  Google Scholar 

  53. Kumar A, Roberts D, Wood KE, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006;34(6):1589–96.

    Article  PubMed  Google Scholar 

  54. Kaasch AJ, Rieg S, Kuetscher J, Brodt HR, preSABATO study group, et al. Delay in the administration of appropriate antimicrobial therapy in Staphylococcus aureus bloodstream infection: a prospective multicenter hospital-based cohort study. Infection. 2013;41(5):979–85.

    Article  CAS  PubMed  Google Scholar 

  55. Garnacho-Montero J, Gutiérrez-Pizarraya A, Escoresca-Ortega A, et al. De-escalation of empirical therapy is associated with lower mortality in patients with severe sepsis and septic shock. Intensive Care Med. 2014;40(1):32–40.

    Article  CAS  PubMed  Google Scholar 

  56. Varpula M, Tallgren M, Saukkonen K, et al. Hemodynamic variables related to outcome in septic shock. Intensive Care Med. 2005;31:1066–71.

    Article  PubMed  Google Scholar 

  57. Dünser MW, Takala J, Ulmer H, et al. Arterial blood pressure during early sepsis and outcome. Intensive Care Med. 2009;35:1225–33.

    Article  PubMed  Google Scholar 

  58. Permpikul C, Sringam P, Tongyoo S. Therapeutic goal achievements during severe sepsis and septic shock resuscitation and their association with patients’ outcomes. J Med Assoc Thai. 2014;97 Suppl 3:S176–83.

    PubMed  Google Scholar 

  59. Beck V, Chateau D, Bryson GL, Cooperative Antimicrobial Therapy of Septic Shock (CATSS) Database Research Group, et al. Timing of vasopressor initiation and mortality in septic shock: a cohort study. Crit Care. 2014;18(3):R97.

    Article  PubMed  PubMed Central  Google Scholar 

  60. Waechter J, Kumar A, Lapinsky SE, Marshall J, Dodek P, Arabi Y, et al. Interaction between fluids and vasoactive agents on mortality in septic shock: a multicentre, observational study. Crit Care Med. 2014;42:2158–68.

    Article  CAS  PubMed  Google Scholar 

  61. Marik P, Bellomo R. A rational approach to fluid therapy in sepsis. Br J Anaesth. 2016;116(3):339–49.

    Article  CAS  PubMed  Google Scholar 

  62. Belletti A, Castro ML, Silvetti S, et al. The effect of inotropes and vasopressors on mortality: a meta-analysis of randomized clinical trials. Br J Anaesth. 2015;115(5):656–75.

    Article  CAS  PubMed  Google Scholar 

  63. Kato R, Pinsky MR. Personalizing blood pressure management in septic shock. Ann Intensive Care. 2015;5(1):41.

    Article  PubMed  PubMed Central  Google Scholar 

  64. Marik PE, Varon J. Goal-directed therapy for severe sepsis. N Engl J Med. 2002;346(13):1025–6.

    Article  PubMed  Google Scholar 

  65. Angus DC, Barnato AE, Bell D, et al. A systematic review and meta-analysis of early goal-directed therapy for septic shock: the ARISE, ProCESS and ProMISe Investigators. Intensive Care Med. 2015;41(9):1549–60.

    Article  CAS  PubMed  Google Scholar 

  66. Peake SL, Bailey M, Bellomo R, ARISE Investigators, for the Australian and New Zealand Intensive Care Society Clinical Trials Group, et al. Australasian resuscitation of sepsis evaluation (ARISE): a multi-centre, prospective, inception cohort study. Resuscitation. 2009;80:811–8.

    Article  PubMed  Google Scholar 

  67. Jones DA, DeVita M, Bellomo R. Rapid-response teams. NEJM. 2011;365(2):139–46.

    Article  CAS  PubMed  Google Scholar 

  68. Cross G, Bilgrami I, Eastwood G, et al. The epidemiology of sepsis during rapid response team reviews in a teaching hospital. Anaesth Intensive Care. 2015;43(2):193–8.

    CAS  PubMed  Google Scholar 

  69. Jones D, Duke G, Green J, et al. Medical emergency team syndromes and an approach to their management. Crit Care. 2006;10(1):R30.

    Article  PubMed  PubMed Central  Google Scholar 

  70. Schneider A, Calzavacca P, Mercer I, et al. The epidemiology and outcome of medical emergency team call patient treated with non-invasive ventilation. Resuscitation. 2011;82(9):1218–23.

    Article  PubMed  Google Scholar 

  71. Jaderling G, Bell M, Martling C, et al. ICU admittance by a rapid response team versus conventional admittance, characteristics, and outcome. Crit Care Med. 2013;41(3):725–31.

    Article  PubMed  Google Scholar 

  72. Miano TA, Powell E, Schweickert WD, et al. Effect of an antibiotic algorithm on the adequacy of empiric antibiotic therapy given by a medical emergency team. J Crit Care. 2012;27(1):45–50.

    Article  PubMed  Google Scholar 

  73. Sarani B, Brenner SR, Gabel B, et al. Improving sepsis care through systems change: the impact of a medical emergency team. Jt Comm J Qual Patient Saf. 2008;34:179–82.

    PubMed  Google Scholar 

  74. Medical Emergency Team End-of-Life Care investigators. The timing of rapid response team activations: a multicentre international study. Crit Care Resusc. 2013;15:15–20.

    Google Scholar 

  75. Considine J, Charlesworth D, Currey J. Characteristics and outcomes of patients requiring rapid response system activation within hours of emergency admission. Crit Care Resusc. 2014;16(3):184–9.

    PubMed  Google Scholar 

  76. McGain F, Cretikos MA, Jones D, et al. Documentation of clinical review and vital signs after major surgery. Med J Aust. 2008;189(7):380–3.

    PubMed  Google Scholar 

  77. Preece MH, Hill A, Horswill MS, et al. Supporting the detection of patient deterioration: observation chart design affects the recognition of abnormal vital signs. Resuscitation. 2012;83(9):1111–8.

    Article  PubMed  Google Scholar 

  78. Currey JP, Jungquist CR. A critical assessment of monitoring practices, patient deterioration, and alarm fatigue on inpatient wards: a review. Patient Saf Surg. 2014;27(8):29.

    Article  Google Scholar 

  79. Burrell AR, McLaws ML, Fullick M, et al. SEPSIS KILLS: early intervention saves lives. Med J Aust. 2016;204(2):73.

    Article  PubMed  Google Scholar 

  80. Nguyen SQ, Mwakalindile E, Booth JS, et al. Automated electronic medical record sepsis detection in the emergency department. Peer J. 2014;2:e343.

    Article  PubMed  PubMed Central  Google Scholar 

  81. Alsolamy S, Al Salamah M, Al Thagafi M, et al. Diagnostic accuracy of a screening electronic alert tool for severe sepsis and septic shock in the emergency department. BMC Med Inform Decis Mak. 2014;14:105.

    Article  PubMed  PubMed Central  Google Scholar 

  82. Australian Commission on Safety and Quality in Health Care. National consensus statement: essential elements for recognising and responding to clinical deterioration. Sydney: ACSQHC, 2010. http://www.safetyandquality.gov.au/internet/safety/publishing.nsf/Content/F329E60CC4149933CA25777 40009229C/$File/national_consensus_statement.pdf (accessed Feb 2016)

Download references

Author information

Authors and Affiliations

  1. Western Hospital-Footscray, 160 Gordon Street, Footscray, VIC, 3011, Australia

    Peter Chan

  2. Department of Intensive Care Medicine, The Queen Elizabeth Hospital, 28 Woodville Rd, Woodville, SA, 5011, Australia

    Sandra Peake

  3. Austin Hospital, The University of Melbourne, Studley Road, Heidelberg, VIC, 3084, Australia

    Rinaldo Bellomo

  4. Intensive Care Unit, Austin Hospital, Studley Road, Heidelberg, VIC, 3084, Australia

    Daryl Jones

  5. Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia

    Daryl Jones

Authors
  1. Peter Chan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sandra Peake
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Rinaldo Bellomo
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Daryl Jones
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Daryl Jones.

Ethics declarations

Conflict of Interest

Drs Chan, Peake, Bellomo and Jones have no conflicts to disclose.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by the author.

Additional information

This article is part of the Topical Collection on Sepsis and ICU

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chan, P., Peake, S., Bellomo, R. et al. Improving the Recognition of, and Response to In-Hospital Sepsis. Curr Infect Dis Rep 18, 20 (2016). https://doi.org/10.1007/s11908-016-0528-7

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11908-016-0528-7

Keywords

Search

Navigation